INT118988

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.10
First Reported 2004
Last Reported 2009
Negated 0
Speculated 0
Reported most in Abstract
Documents 3
Total Number 3
Disease Relevance 1.05
Pain Relevance 1.41

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

extracellular space (Adm) extracellular region (Adm) response to stress (Adm)
cytoplasm (Adm)
Anatomy Link Frequency
nerve 1
Adm (Mus musculus)
Pain Link Frequency Relevance Heat
Calcitonin gene-related peptide 12 100.00 Very High Very High Very High
antagonist 2 100.00 Very High Very High Very High
Neuropeptide 1 99.20 Very High Very High Very High
qutenza 2 97.60 Very High Very High Very High
Inflammation 5 96.88 Very High Very High Very High
Hyperalgesia 1 95.92 Very High Very High Very High
dorsal root ganglion 5 94.92 High High
Spinal cord 2 90.64 High High
IPN 2 83.68 Quite High
spinal dorsal horn 1 73.92 Quite High
Disease Link Frequency Relevance Heat
INFLAMMATION 3 96.88 Very High Very High Very High
Hyperalgesia 2 95.92 Very High Very High Very High
Ganglion Cysts 5 94.92 High High
Inflammatory Pain 2 83.68 Quite High
Hypertension 1 75.00 Quite High
Disease 1 75.00 Quite High
Pain 1 5.00 Very Low Very Low Very Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
Distribution of adrenomedullin (AM)-containing perivascular nerve fibers was studied in rat mesenteric arteries.
Negative_regulation (Distribution) of AM in nerve
1) Confidence 0.10 Published 2004 Journal Peptides Section Abstract Doc Link 15165714 Disease Relevance 0 Pain Relevance 0.21
AM-LI, CGRP-LI, and NPY-LI fibers were abolished by cold storage denervation.
Negative_regulation (abolished) of AM associated with calcitonin gene-related peptide
2) Confidence 0.08 Published 2004 Journal J. Pharmacol. Sci. Section Abstract Doc Link 15599094 Disease Relevance 0.15 Pain Relevance 0.40
The selective antagonist of AM receptors, AM(22-52), administered intrathecally (i.t.) 24 h after CFA injection inhibited inflammation-associated hyperalgesia in a dose-dependent manner (2, 5 and 10 nmol).
Negative_regulation (antagonist) of AM associated with hyperalgesia, inflammation and antagonist
3) Confidence 0.00 Published 2009 Journal Pain Section Abstract Doc Link 19683388 Disease Relevance 0.90 Pain Relevance 0.80

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox